Choi et al. [105] reported that the selective COX-1 inhibitor SC-560 decreased glial stimulation and brain expression of inflammatory markers (e.g., TNF-α) in a mouse model of Alzheimer’s disease. Here, TNF is linked to Alzheimer disease.